MiRNA-152, which directly targets Kruppel-like factor 5 (KLF5) that binds to the promoter region of BAFF and inhibits its expression 101, was reported to be upregulated in B-cells of SLE patients, contributing to B-cell hyperactivation. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.